ATYR
aTyr Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.50
−0.71%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+6.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | SCHIMMEL PAUL · director | Purchase | 100,000 | $0.50 |
| May 13, 2026 | Zaknoen Sara · director | A-Award | 50,000 | $0.95 |
| May 13, 2026 | Lucas Svetlana · director | A-Award | 50,000 | $0.95 |
| May 13, 2026 | SCHIMMEL PAUL · director | A-Award | 50,000 | $0.95 |
| May 13, 2026 | BENEVICH ERIC · director | A-Award | 50,000 | $0.95 |
| May 13, 2026 | Coughlin Timothy · director | A-Award | 50,000 | $0.95 |
| May 13, 2026 | Gross Jane A · director | A-Award | 50,000 | $0.95 |
| Feb 4, 2026 | Shukla Sanjay · director, officer: President and CEO | M-Exempt | 10,375 | $0.00 |
| Feb 4, 2026 | Shukla Sanjay · director, officer: President and CEO | Sale | 3,745 | $0.98 |
| Feb 4, 2026 | Broadfoot Jill Marie · officer: Chief Financial Officer | M-Exempt | 3,750 | $0.00 |
| Feb 4, 2026 | Broadfoot Jill Marie · officer: Chief Financial Officer | Sale | 1,558 | $0.98 |
| Feb 4, 2026 | DENYES NANCY · officer: General Counsel | M-Exempt | 2,687 | $0.00 |
| Feb 4, 2026 | DENYES NANCY · officer: General Counsel | Sale | 1,118 | $0.98 |
| Jan 9, 2026 | Broadfoot Jill Marie · officer: Chief Financial Officer | A-Award | 412,500 | $0.71 |
| Jan 9, 2026 | DENYES NANCY · officer: General Counsel | A-Award | 412,500 | $0.71 |
| Jan 9, 2026 | Shukla Sanjay · director, officer: President and CEO | A-Award | 1,500,000 | $0.71 |
| Oct 9, 2025 | SCHIMMEL PAUL · director | Purchase | 317,999 | $0.94 |
| Oct 9, 2025 | SCHIMMEL PAUL · director | Purchase | 682,001 | $0.90 |
| May 2, 2025 | Lucas Svetlana · director | A-Award | 50,000 | $3.34 |
| May 2, 2025 | Gross Jane A · director | A-Award | 50,000 | $3.34 |
| May 2, 2025 | BENEVICH ERIC · director | A-Award | 50,000 | $3.34 |
| May 2, 2025 | COUGHLIN TIMOTHY · director | A-Award | 50,000 | $3.34 |
| May 2, 2025 | SCHIMMEL PAUL · director | A-Award | 50,000 | $3.34 |
| May 2, 2025 | Zaknoen Sara · director | A-Award | 50,000 | $3.34 |
| Mar 17, 2025 | Gross Jane A · director | Purchase | 3,750 | $4.00 |
| Feb 4, 2025 | Shukla Sanjay · director, officer: President and CEO | M-Exempt | 10,375 | $0.00 |
| Feb 4, 2025 | DENYES NANCY · officer: General Counsel | Sale | 899 | $3.78 |
| Feb 4, 2025 | Broadfoot Jill Marie · officer: Chief Financial Officer | M-Exempt | 3,750 | $0.00 |
| Feb 4, 2025 | Broadfoot Jill Marie · officer: Chief Financial Officer | Sale | 1,254 | $3.78 |
| Feb 4, 2025 | DENYES NANCY · officer: General Counsel | M-Exempt | 2,687 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 28, 2026